Evidence map›Paper›PMID 41461873›Full record

ArticleScientific reports2025

AI-driven antimicrobial peptide characterization unveils novel motifs for drug design.

Sarala Padi, Kinjal Mondal, David P Hoogerheide, Frank Heinrich, Mihaela Mihailescu, Jeffery B Klauda, Antonio Cardone

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sarala PadiInformation Technology Laboratory (ITL), NIST, Gaithersburg, MD, 20899, USA. sarala.padi@nist.gov.
Kinjal MondalInformation Technology Laboratory (ITL), NIST, Gaithersburg, MD, 20899, USA.
David P HoogerheideNIST Center for Neutron Research (NCNR), NIST, Gaithersburg, MD, 20899, USA.
Frank HeinrichNIST Center for Neutron Research (NCNR), NIST, Gaithersburg, MD, 20899, USA.
Mihaela MihailescuInstitute for Bioscience and Biotechnology Research (IBBR), UMD, Rockville, MD, 20850, USA.
Jeffery B KlaudaInstitute for Physical Science and Technology, Biophysics Program, UMD, College Park, MD, 20742, USA.
Antonio CardoneInformation Technology Laboratory (ITL), NIST, Gaithersburg, MD, 20899, USA.

Funding

Innovation in Measurement Science (IMS) grant from the National Institute of Standards and Technology 70NANB17H299 and 70NANB24H248
6 · The paper itself

Abstract

Antibiotics have been developed to effectively target and eliminate bacteria, but the rise in antimicrobial resistance (AR) complicates the treatment of certain infections. To address this issue, researchers have explored antimicrobial peptides (AMPs) that disrupt bacterial membranes. A promising method for this exploration is motif-based analysis, which identifies hidden patterns in AMPs to better understand their mechanism of action. While existing methods rely on expert knowledge, incorporating topic models can enhance analysis by revealing the contextual relationships between sequence elements. This is complemented by a data analytics tool designed to analyze AMP motifs and their biochemical properties. Such integration allows for the extraction of valuable motifs and the development of a robust data analytics module for predicting membrane activity. Additionally, we evaluated the biological relevance of motifs by extracting biochemical features, making structural predictions via Evolutionary Scale Modeling (ESM). Our results indicate that topic model-derived motifs are strongly associated with antimicrobial activity and demonstrate lower minimum inhibitory concentration values and capture contextual information more effectively than traditional frequency-based motifs. We also performed a comparative analysis between the two approaches regarding motif evolution, sequence-level attributes, and entropy measures, ultimately contributing to ongoing efforts to combat AR.

Indexed as

Anti-Bacterial AgentsAntimicrobial PeptidesDrug DesignAmino Acid MotifsMicrobial Sensitivity TestsAnti-Bacterial AgentsAntimicrobial PeptidesAntimicrobial peptidesAntimicrobial resistanceDrug designMinimum inhibitory concentrationMotif extractionTopic model

Identifiers

PMID41461873
PMCPMC12780253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.